Adnan Awad S, Dufva O, Ianevski A, Ghimire B, Koski J, Maliniemi P, Thomson D, Schreiber A, Heckman CA, Koskenvesa P, Korhonen M, Porkka K, Branford S, Aittokallio T, Kankainen M, Mustjoki S(2020) RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses Leukemia(in press) DOI 10.1038/s41375-020-01011-5, PubMed 32782381
Malani D, Yadav B, Kumar A, Potdar S, Kontro M, Kankainen M, Javarappa KK, Porkka K, Wolf M, Aittokallio T, Wennerberg K, Heckman CA, Murumägi A, Kallioniemi O(2020) KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia Leukemia DOI 10.1038/s41375-020-0978-7, PubMed 32678289
Ianevski A, Giri AK, Gautam P, Kononov A, Potdar S, Saarela J, Wennerberg K, Aittokallio T(2019) Prediction of drug combination effects with a minimal set of experiments Nat Mach Intell, 1(12), 568-577 DOI 10.1038/s42256-019-0122-4, PubMed 32368721
